Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Marhefka

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 28, 2018
ROCK inhibitors 2. Improving potency, selectivity and solubility through the application of rationally designed solubilizing groupsHuai Gao, Craig Marhefka, Marc D Jacobs, et al.
Molecular Pharmacology|December 19, 2002
Key structural features of nonsteroidal ligands for binding and activation of the androgen receptorDonghua Yin, Yali He, Minoli A Perera, et al.
Bioorganic & Medicinal Chemistry Letters|August 8, 2018
ROCK inhibitors 3: Design, synthesis and structure-activity relationships of 7-azaindole-based Rho kinase (ROCK) inhibitorsUpul K Bandarage, Jingrong Cao, Jon H Come, et al.
Journal of Medicinal Chemistry|June 4, 2015
Design, Synthesis, and Structure-Activity Relationships of Pyridine-Based Rho Kinase (ROCK) InhibitorsJeremy Green, Jingrong Cao, Upul K Bandarage, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
4-(Benzimidazol-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: potent and selective p70S6 kinase inhibitorsUpul Bandarage, Brian Hare, Jonathan Parsons, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|June 28, 2018
ROCK inhibitors 2. Improving potency, selectivity and solubility through the application of rationally designed solubilizing groupsHuai Gao, Craig Marhefka, Marc D Jacobs, et al.
Molecular Pharmacology|December 19, 2002
Key structural features of nonsteroidal ligands for binding and activation of the androgen receptorDonghua Yin, Yali He, Minoli A Perera, et al.
Bioorganic & Medicinal Chemistry Letters|August 8, 2018
ROCK inhibitors 3: Design, synthesis and structure-activity relationships of 7-azaindole-based Rho kinase (ROCK) inhibitorsUpul K Bandarage, Jingrong Cao, Jon H Come, et al.
Journal of Medicinal Chemistry|June 4, 2015
Design, Synthesis, and Structure-Activity Relationships of Pyridine-Based Rho Kinase (ROCK) InhibitorsJeremy Green, Jingrong Cao, Upul K Bandarage, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
4-(Benzimidazol-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: potent and selective p70S6 kinase inhibitorsUpul Bandarage, Brian Hare, Jonathan Parsons, et al.
Pageof 1